Abbott is now one of the outperforming glamour stocks in US. Over the past 12 months the mega cap is 15 percent higher. The American glamour stocks are 13 percent higher. Investors pay now 30 times the CAPE-ratio per share. The average American glamour stocks are traded at 57.
For this year Abbott 's revenue will be around 238,12 billion USD. This is according to the average of the analysts' estimates. This is slightly lower than 2017's revenue of 242,14 billion USD.
The analysts expect for 2018 a net profit of 22,02 billion USD. Most of the analysts anticipate on a profit per share of 13625,58 USD. Based on this the price/earnings-ratio is 21,58.
Analysts don't expect the company to pay a dividend. The average dividend yield of the pharmaceutical companies is a poor 0,5 percent.Abbott 's market capitalization is based on the number of outstanding shares around 228,3 billion USD.
On Friday, the stock closed at 294055 USD.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.